JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Single-port laparoscopic appendectomy: comparison with conventional laparoscopic appendectomy.

BACKGROUND: Laparoscopic appendectomy is becoming popular for the treatment of acute appendicitis. Since it was first described, laparoscopic appendectomy has been modified various times for reducing pain and improving cosmetic results. Single-port laparoscopic appendectomy (SPLA) may reduce more postoperative trauma and obtain reliable cosmetic results. We compared the safety and feasibility of this technique with those of conventional laparoscopic appendectomy (CLA).

SUBJECTS AND METHODS: Between November 2008 and July 2009, 104 patients were enrolled in this study. Their diagnoses were performed by computed tomography scan. The demographic findings and surgical outcomes such as operation time, pathology, postoperative pain score, hospital stay, and complications of the SPLA group were analyzed and compared with those of the CLA group.

RESULTS: SPLA was completed in 42 patients, and 62 patients underwent CLA. Mean age was 29.9 years in the CLA group and 23.9 years in the SPLA group. The average body mass index of patients was 23.0 kg/m(2) in the CLA group and 20.5 kg/m(2) in the SPLA group. Mean operation time was 55.8 minutes in the CLA group and 51.7 minutes in the SPLA group. There was no conversion to open appendectomy in both groups. No major complications were encountered in the two groups. The mean postoperative hospital stay was 2.9 days for the CLA group and 2.6 days for the SPLA group. There were no deaths in either group.

CONCLUSION: SPLA is a safe technique and shows excellent cosmetic results. This is an easy procedure for an experienced laparoscopic surgeon even with conventional laparoscopic instruments. It remains to be evaluated in cases of perforated appendicitis and periappendiceal abscess.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app